PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2362

  1. 2,953 Posts.
    lightbulb Created with Sketch. 624

    "You would have to imagine the MRI results are underwhelming" you may be right 5cata, would make sense if it was a new drug, however the physical recovery that vets are seeing with animals and is happening to a good percentage of human patients in the early trials, and the way PAR have reacted and changed 008 hints otherwise. Would love to know for sure, however if we knew for sure this would have been taken over or be some crazy $30 a share already.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.